| 别名 | rBPI; BPIFD1; CAP 57; BPI; Bactericidal permeability-increasing protein; |
| 基因名称 | BPI |
| 蛋白名称 | BPI |
| 推荐应用 | |
| 反应物种 | Human |
| 存储缓冲液 | PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA |
| Human Gene Link | 671 |
| Human Swissprot No. | P17213 |
| Mouse Gene ID | 329547 |
| Mouse Swissprot No. | Q67E05 |
| Rat Gene ID | 296321 |
| Rat Swissprot No. | Q6AXU0 |
| 特异性 | Endogenous |
| 稀释度 | WB 1:500~1:2000 |
| 参考分子量 | MW(Observed):54kD |
| 预测分子量 | MW(Calculated):54 kD |
| 运输及保存条件 | -15°C to -25°C/1 year(Do not lower than -25°C) |
| 宿主 | Rabbit |
| 同种型 | IgG,Kappa |
| 背景介绍 | The cytotoxic action of BPI is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. Has antibacterial activity against the Gram-nagative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. |
| 细胞定位 | Secreted, Cytoplasmic granule membrane. |
| 纯化 | Protein A |
| Clonality | Monoclonal |
| 修饰类型 | Unmodified |
| 细胞定位 | Secreted, Cytoplasmic granule membrane. |
| 组织表达 | Spleen, Lung, Liver, Inflammatory tissues, Lung cancer, Lymphoma, Hepatocellular carcinoma. |
周一至周日 8:00-18:00
